Aug 24, 2026 · 39 min
Normal liver tests can miss serious metabolic damage
#405 ‒ AMA #88: Metabolic liver health: how to assess risk, catch dysfunction early, and prevent or reverse liver disease
Liver disease can progress silently, making risk assessment and early detection more consequential than routine enzyme results suggest.
- 1Chronic caloric surplus can drive liver fat, insulin resistance, and progressive metabolic dysfunction.
- 2Controlled human evidence complicates claims that fructose is uniquely more harmful to the liver than glucose.
- 3Alcohol, genetic variants, and hormonal changes can alter susceptibility even when routine liver enzymes appear normal.
Don't miss
Attia challenges the assumption that normal routine liver enzymes reliably indicate a healthy liver.
The brief
Peter Attia frames liver disease as a metabolic process: chronic caloric surplus can increase triglyceride production, impair insulin signaling, and promote lipid accumulation.
The fructose debate is narrower than popular claims suggest. Attia emphasizes controlled human trials and separates their findings from broader animal research.
Alcohol-associated and metabolic liver disease are distinct but overlapping concerns, while self-reported drinking data may understate exposure in population studies.
Inherited susceptibility, including PNPLA3 variants, and changing hormonal factors can influence liver fat, inflammation, and fibrosis risk.
The episode’s sharpest warning arrives with liver testing: normal routine enzymes do not reliably establish that the liver is healthy.
Books & mentions
Some links are affiliate links — PodLume may earn a commission if you buy.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.